laryngeal mask supreme

DEVICE2 trials

Sponsors

Hospital General Universitario Gregorio Marañon, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

Conditions

SevofluraneSupraglottic Airway

Phase 4

Sevoflurane-remifentanil EC50 (The 50% Effective Concentration) Values for LMA-Supreme Versus LMA ProSeal Insertion

CompletedNCT03003377

Hospital General Universitario Gregorio MarañonSevoflurane

Start: 2014-11-30End: 2015-10-31Updated: 2016-12-29

Unknown Phase

Comparison of Video and Classic Laryngeal Mask Airways

Not yet recruitingNCT07361042

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.Supraglottic Airway

Start: 2026-04-01End: 2027-09-30Target: 417Updated: 2026-03-03

Related Papers

Supreme™ laryngeal mask airway insertion requires a lower concentration of sevoflurane than ProSeal™ laryngeal mask airway insertion during target-controlled remifentanil infusion: a prospective randomised controlled study

BMC Anesthesiology2020-01-073 citations